Accor S.A. Inh. sell BiotechBee
Start price
22.09.22
/
60%
€21.98
Target price
31.12.24
€16.00
Performance (%)
8.28%
End price
02.01.23
€23.80
Summary
This prediction ended on 02.01.23 with a price of €23.80. With a performance of 8.28%, the SELL prediction by BiotechBee for Accor S.A. Inh. was trending in the wrong direction BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Accor S.A. Inh. | -2.931% | -2.931% | -2.890% | 68.007% |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% | 64.626% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% | 109.421% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% | 57.591% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% | 68.003% |
According to BiotechBee what are the pros and cons of Accor S.A. Inh. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Accor S.A. Inh. diskutieren
Sell mit Kursziel 16,0